Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Design Therapeutics, Inc. | 1,000,000 | reported | 13 Aug 2025 | tx 20+7,848,002−4,690,479 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Aug 2025 | SALE | Design Therapeutics, Inc. | 217,627 | 5.25 USD | |
| 13 Aug 2025 | SALE | Design Therapeutics, Inc. | 345,000 | 5.25 USD | |
| 10 Jun 2025 | GRANT_AWARD | Design Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 09 Aug 2024 | SALE | Design Therapeutics, Inc. | 814,874 | 4.25 USD | |
| 13 Jun 2024 | GRANT_AWARD | Design Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 28 Aug 2023 | PURCHASE | Design Therapeutics, Inc. | 275,000 | 2.15 USD | first after silence |
| 29 Aug 2023 | PURCHASE | Design Therapeutics, Inc. | 1,960,000 | 2.44 USD | |
| 31 May 2023 | GRANT_AWARD | Design Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | Design Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 21 Mar 2022 | PURCHASE | Design Therapeutics, Inc. | 25,000 | 18.99 USD | |
| 31 Aug 2021 | PURCHASE | Design Therapeutics, Inc. | 40,000 | 15.45 USD | |
| 30 Mar 2021 | CONVERSION | Design Therapeutics, Inc. | 1,217,627 | — | |
| 30 Mar 2021 | PURCHASE | Design Therapeutics, Inc. | 700,000 | 20.00 USD | |
| 30 Mar 2021 | CONVERSION | Design Therapeutics, Inc. | 814,874 | — | |
| 30 Mar 2021 | CONVERSION | Design Therapeutics, Inc. | 1,984,733 | — | deriv |
| 30 Mar 2021 | CONVERSION | Design Therapeutics, Inc. | 1,328,245 | — | deriv |
| 25 Mar 2021 | GRANT_AWARD | Design Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 28 Aug 2023.